Cargando…
Acute Effect of Evolocumab on Lipoprotein(a) Level and Inflammation in Patients with Coronary Artery Disease
Background: Several studies have shown that high plasma lipoprotein(a) concentrations are associated with an increased risk of arteriosclerotic cardiovascular disease. Thus, Lp(a) has emerged as a new therapeutic target. Circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors ar...
Autores principales: | Choi, Seung Woo, Kim, Joan, Jang, Gyeong Won, Lee, Young Shin, Park, Jin Sun, Lee, Jung Myung, Kim, Hyung Oh, Chung, Hyemoon, Woo, Jong Shin, Kim, Woo Shik, Kim, Weon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028952/ https://www.ncbi.nlm.nih.gov/pubmed/35448076 http://dx.doi.org/10.3390/jcdd9040101 |
Ejemplares similares
-
Correlations Between Coronary Artery Disease, Coronary Artery Calcium Score, and Lipoprotein(a) Level in Korea
por: Kim, Joan, et al.
Publicado: (2022) -
Vascular Protective Effects of New Oral Anticoagulants in Patients with Atrial Fibrillation
por: Jang, Gyeong-Won, et al.
Publicado: (2021) -
Long-Term Clinical Effects of Carotid Intraplaque Neovascularization in Patients with Coronary Artery Disease
por: Chung, Hyemoon, et al.
Publicado: (2020) -
Embolic Myocardial Infarction in a Patient with Massive Pulmonary Thromboembolism
por: Woo, Jong Shin, et al.
Publicado: (2017) -
Reduced Coronary Flow Reserve Is Associated with Impaired Ventricular-vascular Interaction in Patients with Obstructive Sleep Apnea
por: Chung, Hyemoon, et al.
Publicado: (2020)